Amplify your productivity Life Science Market Intelligence Agents for You. Unlock critical insights from preclinical pipelines, trial readouts, conferences, journals, market landscapes, investor reports, and more.

As the healthcare industry continues to comb through ASH abstracts for crucial insights before the 2022 annual conference, we at ZoomRx have used Ferma.AI, ZoomRx's comprehensive medical congress intelligence platform, to assemble crucial information in the healthcare market.

Unlock critical insights from trial readouts, comprehensive drug landscapes from discovery to commercial, conferences, journals, investor reports, and more.

Ferma is a Large Language Model (LLM) trained on a vast array of healthcare data. It can analyze your questions, access and analyze the relevant life sciences datasets and generate answers specifically tailored to your questions, in real time.

Leveraging AI for congress CI monitoring enables a broader understanding of scientific information across an ecosystem of data that are available at large meetings. AI efficiently retrieved presentations of interest and performed objective tasks quickly relative to traditional CI collection methods.

Jul 28, 2023 · Ferma is a conversational AI platform that has been designed specifically for pharma and biotech professionals. Ferma offers superior accuracy when compared to other general-purpose models by leveraging a sophisticated knowledge graph as well as fine-tuning specific for the life sciences sector.

Our Ferma.AI team offers an Artificial Intelligence tool for conference coverage and competitive intelligence. What for? (Purpose)

Get Unlimited Access to ASH24 Insights. Book a Demo

Amplify your productivity Life Science Market Intelligence Agents for You. Unlock critical insights from preclinical pipelines, trial readouts, conferences, journals, market landscapes, investor reports, and more.

ferma.AI is an independent publication launched in January 2023 by Jaikumar. If you subscribe today, you'll get full access to the website as well as email newsletters about new content when it's available.